176 related articles for article (PubMed ID: 21724534)
21. Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF.
Merhi Z; Buyuk E; Berger DS; Zapantis A; Israel DD; Chua S; Jindal S
Hum Reprod; 2013 Jun; 28(6):1661-9. PubMed ID: 23503941
[TBL] [Abstract][Full Text] [Related]
22. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
23. Anti-Müllerian hormone and polycystic ovary syndrome.
Bhide P; Homburg R
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234
[TBL] [Abstract][Full Text] [Related]
24. Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women.
Stracquadanio M; Ciotta L; Palumbo MA
Gynecol Endocrinol; 2018 Mar; 34(3):223-228. PubMed ID: 28944702
[TBL] [Abstract][Full Text] [Related]
25. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
Chen X; Yin M; Ye D; He Y; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
[TBL] [Abstract][Full Text] [Related]
26. [The anti-mullerian hormone--physiology and application into clinical practice].
Robeva R; Mekhandzhiev Ts; Tomova A; Kumanov F
Akush Ginekol (Sofiia); 2006; 45(7):50-4. PubMed ID: 17489169
[TBL] [Abstract][Full Text] [Related]
27. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
28. Expression of anti-Müllerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries.
Ball BA; Conley AJ; MacLaughlin DT; Grundy SA; Sabeur K; Liu IK
Theriogenology; 2008 Oct; 70(6):968-77. PubMed ID: 18599114
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
[TBL] [Abstract][Full Text] [Related]
30. [Determination of anti-Müllerian hormone in women].
Kučera R; Topolčan O; Rumpíková T; Rumpík D; Dostál J
Ceska Gynekol; 2013 Jun; 78(3):282-8. PubMed ID: 23869836
[TBL] [Abstract][Full Text] [Related]
31. [Measurement of serum AMH levels in gynecology: indications and limits].
Streuli I; Cantero-Perez P; Miserez-Zaugg C
Rev Med Suisse; 2013 Oct; 9(403):1954-6, 1958. PubMed ID: 24245018
[TBL] [Abstract][Full Text] [Related]
32. Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
Christiansen SC; Eilertsen TB; Vanky E; Carlsen SM
PLoS One; 2016; 11(1):e0146739. PubMed ID: 26799212
[TBL] [Abstract][Full Text] [Related]
33. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
34. Recent progress in the utility of anti-Müllerian hormone in female infertility.
Grynnerup AG; Lindhard A; Sørensen S
Curr Opin Obstet Gynecol; 2014 Jun; 26(3):162-7. PubMed ID: 24722366
[TBL] [Abstract][Full Text] [Related]
35. Anti-Müllerian hormone testing: Evaluation of a novel method allowing more automation.
De Laveleye M; Gruson D
Scand J Clin Lab Invest; 2015; 75(8):681-5. PubMed ID: 26359323
[TBL] [Abstract][Full Text] [Related]
36. [What's new in 2014 about anti-Müllerian hormone?].
Seroka-Vanhove A; Sonigo C; Roche C; Grynberg M
J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):559-71. PubMed ID: 25042625
[TBL] [Abstract][Full Text] [Related]
37. Association between BMI and gene expression of anti-Müllerian hormone and androgen receptor in human granulosa cells in women with and without polycystic ovary syndrome.
Nouri M; Aghadavod E; Khani S; Jamilian M; Amiri Siavashani M; Ahmadi S; Asemi Z
Clin Endocrinol (Oxf); 2016 Oct; 85(4):590-5. PubMed ID: 27163385
[TBL] [Abstract][Full Text] [Related]
38. [Anti-Müllerian hormone: A brief review of the literature].
Ozzola G
Clin Ter; 2017; 168(1):e14-e22. PubMed ID: 28240757
[TBL] [Abstract][Full Text] [Related]
39. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
40. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
